FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Roeder

Research Profile

Chemicals & Drugs

Living Beings

Concepts & Ideas

Procedures

Physiology

Pregnancy

Disorders

Neurologic Kindling

Co-author Network

Publications

TOP 3
Nina Isoherranen; Ofer Spiegelstein; Meir Bialer; Jing Zhang; Michelle Merriweather; Boris Yagen; Michael Roeder; Aleata A Triplett; Volker Schurig; Richard Finnell
Developmental outcome of levetiracetam, its major metabolite in humans, 2-pyrrolidinone N-butyric acid, and its enantiomer (R)-alpha-ethyl-oxo-pyrrolidine acetamide in a mouse model of teratogenicity.
Nina Isoherranen; H White; Brian D Klein; Michael Roeder; José H Woodhead; Volker Schurig; Boris Yagen; Meir Bialer
Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy.
Nina Isoherranen; Boris Yagen; Stefan Soback; Michael Roeder; Volker Schurig; Meir Bialer
Pharmacokinetics of levetiracetam and its enantiomer (R)-alpha-ethyl-2-oxo-pyrrolidine acetamide in dogs.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Roeder (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Nina Isoherranen; Ofer Spiegelstein; Meir Bialer; Jing Zhang; Michelle Merriweather; Boris Yagen; Michael Roeder; Aleata A Triplett; Volker Schurig; Richard Finnell
Developmental outcome of levetiracetam, its major metabolite in humans, 2-pyrrolidinone N-butyric acid, and its enantiomer (R)-alpha-ethyl-oxo-pyrrolidine acetamide in a mouse model of teratogenicity.
Epilepsia 2003;44(10):1280-8.
2003: Nina Isoherranen; H White; Brian D Klein; Michael Roeder; José H Woodhead; Volker Schurig; Boris Yagen; Meir Bialer
Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy.
Pharmaceutical research 2003;20(8):1293-301.
2001: Nina Isoherranen; Boris Yagen; Stefan Soback; Michael Roeder; Volker Schurig; Meir Bialer
Pharmacokinetics of levetiracetam and its enantiomer (R)-alpha-ethyl-2-oxo-pyrrolidine acetamide in dogs.
Epilepsia 2001;42(7):825-30.
2000: Roswitha Schmidt; Michael Roeder; O Oeckler; A Simon; Volker Schurig
Separation and absolute configuration of the enantiomers of a degradation product of the new inhalation anesthetic sevoflurane.
Chirality 2000;12(10):751-5.
2000: Nina Isoherranen; Michael Roeder; Stefan Soback; Boris Yagen; Volker Schurig; Meir Bialer
Enantioselective analysis of levetiracetam and its enantiomer R-alpha-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detection.
Journal of chromatography. B, Biomedical sciences and applications 2000;745(2):325-32.
1999: Ofer Spiegelstein; Boris Yagen; René H Levy; Richard Finnell; Gregory D Bennett; Michael Roeder; Volker Schurig; Meir Bialer
Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acid.
Pharmaceutical research 1999;16(10):1582-8.
1998: Dorothee Wistuba; Harri Czesla; Michael Roeder; Volker Schurig
Enantiomer separation by pressure-supported electrochromatography using capillaries packed with a permethyl-beta-cyclodextrin stationary.
Journal of chromatography. A 1998;815(2):183-8.